Bamlanivimab recall in Canada: English-only labels
In plain language
This recall involves Bamlanivimab for injection sold in Canada. It's being recalled because the labels are in English only and lack important Canadian-specific information. Healthcare professionals should use the Canadian Product Monograph for complete information.
What to do
- Healthcare professionals should consult the Canadian Product Monograph for complete product information.
- Access the Canadian-specific labelling information online.
- Disregard the "For Use Under Emergency Use Authorization (EUA)" statement on the labels.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Bamlanivimab for injection, Anti-SARS-CoV-2 spike protein monoclonal antibody, solution for infusion, 700 mg/20 mL (35 mg/mL), Single-dose vial
Model: DIN 02508176
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 02508176
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Bamlanivimab for injection sold in Canada. It's being recalled because the labels are in English only and lack important Canadian-specific information. Healthcare professionals should use the Canadian Product Monograph for complete information.
What should consumers do?
Healthcare professionals should consult the Canadian Product Monograph for complete product information. Access the Canadian-specific labelling information online. Disregard the "For Use Under Emergency Use Authorization (EUA)" statement on the labels.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on December 18, 2020.
Is the Bamlanivimab brand affected by this recall?
Yes, Bamlanivimab products are affected by this recall. This recall involves Bamlanivimab for injection sold in Canada. It's being recalled because the labels are in English only and lack important Canadian-specific information. Healthcare professionals should use the Canadian Product Monograph for complete information.